Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention
Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention
- We randomly assigned HIV-infected women at 14 or more weeks of gestation with CD4 counts of at least 350 cells per cubic millimeter to zidovudine ...
- We randomly assigned HIV-infected women at 14 or more weeks of gestation with CD4 counts of at least 350 cells per cubic millimeter to zidovudine ...